DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world.
Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits.
DiogenX is headquartered in Marseille, with labs in Nice (France).
Company Details
- Employees
- 19
- Founded
- -
- Address
- Marseille, Fr
- Industry
- Biotechnology
- Website
- diogenx.com
- Keywords
- Biotechnology and Diabetes.
- HQ
- Marseille
Diogenx Questions
Diogenx's website is diogenx.com
Diogenx's LinkedIn profile is https://fr.linkedin.com/company/diogenx
Diogenx has
19 employees.
View email and phone details for 19
employees at Diogenx.
Diogenx's industry is
Biotechnology
Diogenx's top competitors are
Cilcare,
Corteria Pharmaceuticals,
Mnemo Therapeutics,
Enyo Pharma,
Sparingvision,
Enterome,
Coave Therapeutics,
Nanobiotix,
Eligo Bioscience,
Imcheck Therapeutics.
Diogenx's categories are Biotechnology
Diogenx's founding year is 2020
